Comparison of Etomidate Plus Propofol, Etomidate Alone on Induction of Anesthesia
NCT ID: NCT03820388
Last Updated: 2021-02-23
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
75 participants
INTERVENTIONAL
2017-12-01
2018-07-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Etomidate/Propofol Mixture or Propofol Monotherapy Use in Patients Undergoing General Anesthesia
NCT03855267
Does Administration of Etomidate and Propofol of the Anesthetic Induction of Elderly Hypertensive Patient Provide Superior Blood Pressure Stability in Response to Direct Laryngoscopy When Compared to Propofol or Etomidate Alone?
NCT01248234
Comparison of Etomidate, Propofol and Etomidate-propofol Combination in Terms of Effects on Haemodynamic Response to Intubation
NCT02186990
Comparison of Propofol to Precedex With Propofol for Emergence and Recovery in Patients Having Craniotomy Surgery
NCT00848991
Efficacy of Ketamine-Propofol for Short Surgical Procedures
NCT01651988
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Propofol Group
Propofol 2 mg/kg
Propofol 2mg/kg
2 mg/kg
Etomidate Group
Etomidate 0.3 mg/kg
Etomidate 0.3 mg/kg
0.3 mg/kg
Propofol plus Etomidate Group
Propofol 1 mg/kg plus Etomidate 0.15 mg/kg
Propofol 1 mg/kg
1 mg/kg Propofol
Etomidate 0.15 mg/kg
0.15 mg/kg Etomidate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Propofol 2mg/kg
2 mg/kg
Etomidate 0.3 mg/kg
0.3 mg/kg
Propofol 1 mg/kg
1 mg/kg Propofol
Etomidate 0.15 mg/kg
0.15 mg/kg Etomidate
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA physical status of 2 or 3
* Age equal to or greater than 18 years old
Exclusion Criteria
* Age less than 18 years old
* Pregnant women
* Prisoners
* Difficult airway
* Morbid Obesity
* Preoperative sedation use
* Severe Cardiac, pulmonary and liver disease
* Hypotension and shock
* Emergency surgeries
* Allergy to propofol or etomidate
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hong Liu, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, Davis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California Davis Medical Center
Sacramento, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
909765
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.